News

Barchart on MSN22h
This Dividend Stock Yields Nearly 8% and Trades at Depressed Valuations: Time to Buy?
Pfizer (PFE) investors are bound to be disappointed with the stock’s price action. With a year-to-date loss of 16.7% as of ...
Zacks Investment Research on MSN23h
Pfizer (PFE) Laps the Stock Market: Here's Why
In the latest trading session, Pfizer (PFE) closed at $22.15, marking a +0.48% move from the previous day. The stock exceeded the S&P 500, which registered a gain of 0.13% for the day. On the other ...
Pfizer Abandons Its Leading Weight Loss Candidate. Should You Sell the Stock?
Pfizer has encountered many setbacks in its quest to launch a medicine that could rival Wegovy and Zepbound. One of its ...